Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Short, Open, Phase 0 Study to Demonstrate the Viability of the Lozenge Dosage Form to Deliver SALI-10 Oral Probiotics

NCT06819761 is registered in ClinicalTrials.gov with Ostia Sciences as lead sponsor.

NCT NCT06819761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06819761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Short, Open, Phase 0 Study to Demonstrate the Viability of the Lozenge Dosage Form to Deliver SALI-10 Oral Probiotics
Lead sponsor
Ostia Sciences
Phase
Not applicable
Overall status
Completed
Start date
March 6, 2025
Completion date
June 30, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delivery systems, oral health